Physician profile
Tehreem Sajjad
NPI 1649895848
$8,554.59
in general payments reported to CMS, 2019-2025
14 companies · $2,366 in 2025
The $2,366 reported for 2025 was more than what 92% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $118 · 2021: $3,109 · 2022: $419 · 2023: $2,376 · 2024: $168 · 2025: $2,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,028 · Food and Beverage: $1,882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,027.70 |
| Food and Beverage | $1,881.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,422.31 | 2021 | |
| Smith+Nephew, INC. | $2,406.52 | 2020-2025 | Pico, Collagenase Santyl, Grafix |
| Orthofix Medical, INC. | $2,044.97 | 2023 | Truelok |
| Medical Device Business Services, INC. | $498.58 | 2021 | |
| Inari Medical, INC. | $351.65 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Integra Lifesciences Corporation | $176.41 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $144.12 | 2022 | |
| Bioventus LLC | $118.44 | 2021 | |
| Stryker Corporation | $102.62 | 2020-2022 | |
| Hydrofera LLC | $101.00 | 2024-2025 | Hydrofera Blue |
| Medtronic, INC. | $94.44 | 2023 | Venaseal |
| Convatec INC. | $67.62 | 2022 | |
| Organogenesis INC. | $16.98 | 2024 | Affinity |
| Medela LLC | $8.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tehreem Sajjad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.